ADVANCED SUPPLEMENTS - HEALING & GROWTH
AFRICANUM - Damaged Tissue Rebuilder
WHAT IS IT?
Body Ripped AFRICANUM is a highly advanced natural SARM (Selective Androgen Receptor Modulator), which has been extensively tested and clinically proven to offer a natural alternative to chemical SARMs.
WHAT DOES IT DO?
Pygeum Africanum is an extract made from the the bark of the Prunus Africana tree, and is commonly known for its use in the treatment of Benign Prostatic Hyperplasia (BPH).
Pygeum Africanum may also reduce prostatic cell proliferation, and has been noted to interfere with prostatic growth factors.
Of most interest to the bodybuilding and athletic community, however, is Pygeum Africanum’s liver protection action, as well as its potential ability to rebuild damaged tissue.
Extensive literature shows that AFRICANUM may offer many health benefits, such as:
● Potential reduction of Benign Prostatic Hyperplasia (BPH)
● Protection of the liver, and potential ability to rebuild damaged tissue
● Increase in bone density
● Increase in muscle mass, while decreasing adipose mass (body fat)
● Decrease in estrogen production, leading to slight increase in testosterone
WHEN DO I TAKE IT?
Adults take 1 capsule, three times daily with food, or as recommended by your Healthcare Professional.
Body Ripped AFRICANUM can be used at any time of the day.
WHAT’S IN IT?
Creatine Monohydrate (Creapure), Androgen Receptor Complete SARM-Pygeum Africanum Standardised to Methyl Atrarate, Piperine.
Serajuddin, A., Sheen, P. C., & Augustine, M. A. (1990). Improved dissolution of a poorly water‐soluble drug from solid dispersions in polyethylene glycol: polysorbate 80 mixtures. Journal of pharmaceutical sciences, 79(5), 463-464.
Briley, M., Carilla, E., & Fauran, F. (1983). Permixon, a new treatment for benign prostatic hyperplasia, acts directly at the cytosolic androgen receptor in rat prostate. Br J Pharmacol, 79, 327P.
Carilla, E., Briley, M., Fauran, F., Sultan, C. H., & Duvilliers, C. (1984). Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. Journal of steroid biochemistry, 20(1), 521-523.
Cabeza, M., Bratoef, E., Heuze, I., Ramírez, E., Sánchez, M., & Flores, E. (2003). Effect of beta-sitosterol as Inhibitor of 5alpha-reductase in Hamster Prostate. In Proceedings-Western Pharmacology Society (Vol. 46, pp. 153-155). [Western Pharmacology Society]; 1998.